Charlotte Allerton

3.1k total citations
13 papers, 455 citations indexed

About

Charlotte Allerton is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Charlotte Allerton has authored 13 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Infectious Diseases. Recurrent topics in Charlotte Allerton's work include SARS-CoV-2 and COVID-19 Research (2 papers), Computational Drug Discovery Methods (2 papers) and Pharmaceutical Economics and Policy (2 papers). Charlotte Allerton is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Computational Drug Discovery Methods (2 papers) and Pharmaceutical Economics and Policy (2 papers). Charlotte Allerton collaborates with scholars based in United States and United Kingdom. Charlotte Allerton's co-authors include Manthena V. S. Varma, Ayman El‐Kattan, Stefanus J. Steyn, Henry‐Georges Lombart, Ian Paterson, Graham N. Maw, Julian Blagg, Kathrin U. Jansen, Michael S. Vincent and Kevin Beaumont and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Medicinal Chemistry and Organic Letters.

In The Last Decade

Charlotte Allerton

13 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charlotte Allerton United States	9	146	143	139	127	77	13	455
Tim F. Ryder United States	11	264 1.8×	148 1.0×	196 1.4×	81 0.6×	66 0.9×	20	659
William F. Pool United States	12	235 1.6×	123 0.9×	166 1.2×	62 0.5×	61 0.8×	20	496
Matthew A. Cerny United States	14	349 2.4×	218 1.5×	170 1.2×	91 0.7×	99 1.3×	25	655
Toshio Teramura Japan	13	276 1.9×	177 1.2×	156 1.1×	57 0.4×	44 0.6×	28	609
Tonika Bohnert United States	9	61 0.4×	138 1.0×	228 1.6×	94 0.7×	77 1.0×	9	558
Stella Vincent United States	16	145 1.0×	182 1.3×	285 2.1×	100 0.8×	34 0.4×	35	712
Faraz Kazmi United States	10	246 1.7×	156 1.1×	194 1.4×	42 0.3×	55 0.7×	17	591
James Atherton United States	10	135 0.9×	80 0.6×	115 0.8×	55 0.4×	40 0.5×	11	405
Vinita Uttamsingh United States	11	166 1.1×	156 1.1×	219 1.6×	43 0.3×	37 0.5×	18	562
Hequn Yin United States	11	188 1.3×	161 1.1×	194 1.4×	35 0.3×	65 0.8×	20	508

Countries citing papers authored by Charlotte Allerton

Since Specialization

Citations

This map shows the geographic impact of Charlotte Allerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Allerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Allerton more than expected).

Fields of papers citing papers by Charlotte Allerton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Allerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Allerton. The network helps show where Charlotte Allerton may publish in the future.

Co-authorship network of co-authors of Charlotte Allerton

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Allerton. A scholar is included among the top collaborators of Charlotte Allerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Allerton. Charlotte Allerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Singh, Ravi Shankar Prasad, Luke F. Chen, Jin Hyang Kim, et al.. (2024). Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19. Clinical Infectious Diseases. 80(3). 673–680. 3 indexed citations

Baniecki, Mary Lynn, Zhenyu Wang, Yan Chen, et al.. (2023). 361. Evaluation of Resistance to Nirmatrelvir/ritonavir in Evaluation of Protease Inhibition for COVID-19 (EPIC) High-Risk and Standard-Risk Clinical Trials. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Prigodich, Andrew E., Patrick R. Verhoest, Nicholas W. Warne, et al.. (2021). Innovation in breakthrough drugs and vaccines: Development risk, patient impact, and value. Drug Discovery Today. 26(10). 2232–2237. 2 indexed citations

Maurer, Tristan S., Martin P. Edwards, David Hepworth, Patrick R. Verhoest, & Charlotte Allerton. (2021). Designing small molecules for therapeutic success: A contemporary perspective. Drug Discovery Today. 27(2). 538–546. 17 indexed citations

Allerton, Charlotte, et al.. (2020). Reviving an R&D pipeline: a step change in the Phase II success rate. Drug Discovery Today. 26(2). 308–314. 24 indexed citations

Varma, Manthena V. S., Stefanus J. Steyn, Charlotte Allerton, & Ayman El‐Kattan. (2015). Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research. 32(12). 3785–3802. 223 indexed citations

Allerton, Charlotte, Mark D. Andrews, Julian Blagg, et al.. (2009). Design and synthesis of pyridazinone-based 5-HT2C agonists. Bioorganic & Medicinal Chemistry Letters. 19(19). 5791–5795. 27 indexed citations

Andrews, Mark D., Charlotte Allerton, Julian Blagg, et al.. (2009). Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT2C agonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5346–5350. 5 indexed citations

Blagg, Julian, Charlotte Allerton, Christopher L. Carr, et al.. (2007). Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route. Bioorganic & Medicinal Chemistry Letters. 17(24). 6691–6696. 12 indexed citations

10.

Bunnage, Mark E., Julian Blagg, John Steele, et al.. (2007). Discovery of Potent & Selective Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor for the Treatment of Thrombosis. Journal of Medicinal Chemistry. 50(24). 6095–6103. 36 indexed citations

11.

Allerton, Charlotte, Chris Barber, Kevin Beaumont, et al.. (2006). A Novel Series of Potent and Selective PDE5 Inhibitors with Potential for High and Dose-Independent Oral Bioavailability. Journal of Medicinal Chemistry. 49(12). 3581–3594. 18 indexed citations

12.

Maw, Graham N., et al.. (2003). Design, synthesis and biological activity of β-carboline-based type-5 phosphodiesterase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1425–1428. 41 indexed citations

13.

Paterson, Ian, Henry‐Georges Lombart, & Charlotte Allerton. (1999). Total Synthesis of Elaiolide Using a Copper(I)-Promoted Stille Cyclodimerization Reaction. Organic Letters. 1(1). 19–22. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact